ORAGENICS, INC. (OGEN) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
10/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 0 wins, 12 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseOGEN / S&P 3.57% / 15.20% |
LoseOGEN / S&P OGEN unavailable / 15.00% |
LoseOGEN / S&P -106.89% / 50.40% |
| 2026-Q10/3 |
LoseOGEN / S&P -28.21% / -4.33% |
LoseOGEN / S&P OGEN unavailable / 11.30% |
LoseOGEN / S&P -121.38% / 27.70% |
| 2025-Q40/3 |
LoseOGEN / S&P -40.46% / 2.65% |
LoseOGEN / S&P OGEN unavailable / 9.00% |
LoseOGEN / S&P -130.95% / 13.40% |
| 2025-Q30/3 |
LoseOGEN / S&P -65.71% / 8.12% |
LoseOGEN / S&P OGEN unavailable / 4.61% |
LoseOGEN / S&P -236.65% / 13.45% |
| 2025-Q20/3 |
LoseOGEN / S&P -39.37% / 10.94% |
LoseOGEN / S&P OGEN unavailable / 4.83% |
LoseOGEN / S&P -258.83% / 10.63% |
| 2025-Q10/3 |
LoseOGEN / S&P -43.24% / -4.27% |
LoseOGEN / S&P OGEN unavailable / 4.98% |
LoseOGEN / S&P -372.25% / 10.57% |
| 2024-Q40/3 |
LoseOGEN / S&P -2.63% / 2.41% |
LoseOGEN / S&P OGEN unavailable / 5.25% |
LoseOGEN / S&P -383.24% / 6.15% |
| 2024-Q31/3 |
LoseOGEN / S&P -63.46% / 5.89% |
LoseOGEN / S&P OGEN unavailable / 5.89% |
WinOGEN / S&P 601.71% / 6.11% |
| 2024-Q21/3 |
LoseOGEN / S&P -27.78% / 4.28% |
LoseOGEN / S&P OGEN unavailable / 5.38% |
WinOGEN / S&P 283.82% / 5.12% |
| 2024-Q11/3 |
LoseOGEN / S&P -74.42% / 10.56% |
LoseOGEN / S&P OGEN unavailable / 5.71% |
WinOGEN / S&P 38.86% / 5.59% |
| 2023-Q41/3 |
WinOGEN / S&P 89.56% / 11.69% |
LoseOGEN / S&P -71.37% / 6.81% |
LoseOGEN / S&P OGEN unavailable / 7.78% |
| 2023-Q30/3 |
LoseOGEN / S&P -10.27% / -3.27% |
LoseOGEN / S&P OGEN unavailable / 7.52% |
LoseOGEN / S&P OGEN unavailable / -5.03% |
| 2023-Q20/3 |
LoseOGEN / S&P 0.61% / 8.74% |
LoseOGEN / S&P OGEN unavailable / 9.50% |
LoseOGEN / S&P OGEN unavailable / -8.57% |
| 2023-Q10/3 |
LoseOGEN / S&P -50.15% / 7.50% |
LoseOGEN / S&P OGEN unavailable / 10.77% |
LoseOGEN / S&P OGEN unavailable / -15.69% |
| 2022-Q40/3 |
LoseOGEN / S&P -52.17% / 7.56% |
LoseOGEN / S&P OGEN unavailable / 11.88% |
LoseOGEN / S&P OGEN unavailable / -17.99% |
| 2022-Q30/3 |
LoseOGEN / S&P -34.29% / -4.88% |
LoseOGEN / S&P OGEN unavailable / 13.47% |
LoseOGEN / S&P OGEN unavailable / -1.41% |
| 2022-Q21/3 |
WinOGEN / S&P 2.94% / -16.10% |
LoseOGEN / S&P OGEN unavailable / 13.71% |
LoseOGEN / S&P OGEN unavailable / 11.04% |
| 2022-Q10/3 |
LoseOGEN / S&P -24.44% / -4.60% |
LoseOGEN / S&P OGEN unavailable / 15.97% |
LoseOGEN / S&P OGEN unavailable / 42.23% |
| 2021-Q40/3 |
LoseOGEN / S&P -28.57% / 11.03% |
LoseOGEN / S&P OGEN unavailable / 15.00% |
LoseOGEN / S&P OGEN unavailable / 96.40% |
| 2021-Q30/3 |
LoseOGEN / S&P -11.27% / 0.58% |
LoseOGEN / S&P OGEN unavailable / 10.77% |
LoseOGEN / S&P OGEN unavailable / 69.42% |
| 2021-Q20/3 |
LoseOGEN / S&P -21.98% / 8.55% |
LoseOGEN / S&P OGEN unavailable / 6.58% |
LoseOGEN / S&P OGEN unavailable / 51.81% |
| 2021-Q11/3 |
WinOGEN / S&P 102.22% / 6.17% |
LoseOGEN / S&P OGEN unavailable / -1.06% |
LoseOGEN / S&P OGEN unavailable / 7.39% |
| 2020-Q40/3 |
LoseOGEN / S&P -21.05% / 12.15% |
LoseOGEN / S&P OGEN unavailable / -3.72% |
LoseOGEN / S&P OGEN unavailable / -33.42% |
| 2020-Q30/3 |
LoseOGEN / S&P -17.39% / 8.93% |
LoseOGEN / S&P OGEN unavailable / -2.04% |
LoseOGEN / S&P OGEN unavailable / -27.10% |
| 2020-Q20/3 |
LoseOGEN / S&P 18.97% / 20.54% |
LoseOGEN / S&P OGEN unavailable / -0.46% |
LoseOGEN / S&P OGEN unavailable / -27.11% |
| 2020-Q11/3 |
WinOGEN / S&P 11.54% / -19.60% |
LoseOGEN / S&P OGEN unavailable / 3.47% |
LoseOGEN / S&P OGEN unavailable / -14.75% |
| 2019-Q40/3 |
LoseOGEN / S&P -3.70% / 9.07% |
LoseOGEN / S&P OGEN unavailable / 5.36% |
LoseOGEN / S&P OGEN unavailable / 2.99% |
| 2019-Q31/3 |
WinOGEN / S&P 10.20% / 1.70% |
LoseOGEN / S&P OGEN unavailable / 5.02% |
LoseOGEN / S&P OGEN unavailable / 0.21% |
| 2019-Q20/3 |
LoseOGEN / S&P -16.95% / 4.30% |
LoseOGEN / S&P OGEN unavailable / 6.64% |
LoseOGEN / S&P OGEN unavailable / 8.65% |
| 2019-Q10/3 |
LoseOGEN / S&P -31.40% / 13.65% |
LoseOGEN / S&P OGEN unavailable / 8.12% |
LoseOGEN / S&P OGEN unavailable / 14.29% |
| 2018-Q40/3 |
LoseOGEN / S&P -25.22% / -13.52% |
LoseOGEN / S&P OGEN unavailable / 9.05% |
LoseOGEN / S&P OGEN unavailable / 18.23% |
| 2018-Q30/3 |
LoseOGEN / S&P -16.67% / 7.71% |
LoseOGEN / S&P OGEN unavailable / 10.21% |
LoseOGEN / S&P OGEN unavailable / 19.06% |
| 2018-Q20/3 |
LoseOGEN / S&P -20.69% / 3.43% |
LoseOGEN / S&P OGEN unavailable / 9.03% |
LoseOGEN / S&P OGEN unavailable / 14.46% |
| 2018-Q10/3 |
LoseOGEN / S&P -24.35% / -0.76% |
LoseOGEN / S&P OGEN unavailable / 7.68% |
LoseOGEN / S&P OGEN unavailable / 12.46% |
| 2017-Q40/3 |
LoseOGEN / S&P -45.24% / 6.64% |
LoseOGEN / S&P OGEN unavailable / 7.03% |
LoseOGEN / S&P OGEN unavailable / 13.82% |
| 2017-Q31/3 |
WinOGEN / S&P 13.51% / 4.48% |
LoseOGEN / S&P OGEN unavailable / 5.68% |
LoseOGEN / S&P OGEN unavailable / 17.57% |
| 2017-Q20/3 |
LoseOGEN / S&P -15.91% / 3.09% |
LoseOGEN / S&P OGEN unavailable / 4.83% |
LoseOGEN / S&P OGEN unavailable / 17.74% |
| 2017-Q10/3 |
LoseOGEN / S&P -18.52% / 6.07% |
LoseOGEN / S&P OGEN unavailable / 3.67% |
LoseOGEN / S&P OGEN unavailable / 13.32% |
| 2016-Q41/3 |
WinOGEN / S&P 17.39% / 3.82% |
LoseOGEN / S&P -27.91% / 2.09% |
LoseOGEN / S&P OGEN unavailable / 7.05% |
| 2016-Q30/3 |
LoseOGEN / S&P -9.80% / 3.85% |
LoseOGEN / S&P -55.11% / 0.20% |
LoseOGEN / S&P OGEN unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | OGEN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -48.54% | 20.78% |
| Annualized return | -48.54% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | OGEN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.96% | 83.14% |
| Annualized return | -78.94% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | OGEN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 319.30% |
| Annualized return | -63.22% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |